Global Antibody Services Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Antibody Services Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Antibody Services Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 Monoclonal
  • 1.2.3 Polyclonal
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Antibody Services Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 BioScience Companies
  • 1.3.3 BioScience Research Institutions
  • 1.3.4 Hospitals
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Antibody Services Market Size Estimates and Forecasts
• 2.2 Antibody Services Market Size by Region: 2024 Versus 2031
  • 2.2.1 Global Antibody Services Revenue by Region: 2020-2025
  • 2.2.2 Global Antibody Services Revenue Forecast by Region (2026-2031)
  • 2.2.3 Global Antibody Services Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Antibody Services Revenue by Type (2020-2031)
  • 3.1.2 Global Antibody Services Revenue Market Share by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Antibody Services Revenue by Application (2020-2031)
  • 3.2.2 Global Antibody Services Revenue Market Share by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 Monoclonal of Antibody Services Revenue Market Share by Application
  • 3.3.2 Polyclonal of Antibody Services Revenue Market Share by Application
  • 3.3.3 Others of Antibody Services Revenue Market Share by Application

4 Global Antibody Services by Company

• 4.1 Global Antibody Services Revenue by Company (2020-2025)
• 4.2 Global Antibody Services Revenue Share by Company (2020-2025)
• 4.3 Competitive Landscape
  • 4.3.1 Key Antibody Services Companies around the World: Ranking by Revenue
  • 4.3.2 Global Antibody Services Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.3.3 Global Antibody Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.4 Global Antibody Services Companies Headquarters & Product Type
  • 4.4.1 Global Antibody Services Companies Headquarters
  • 4.4.2 Date of International Companies Enter into Antibody Services Market
  • 4.4.3 Global Antibody Services Companies Product & Service
  • 4.4.4 Monoclonal Revenue Market Share of Antibody Services by Company
  • 4.4.5 Polyclonal Revenue Market Share of Antibody Services by Company
  • 4.4.6 Others Revenue Market Share of Antibody Services by Company
• 4.5 Global Antibody Services Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 ThermoFisher
  • 5.1.1 ThermoFisher Corporation Information
  • 5.1.2 ThermoFisher Description, Business Overview
  • 5.1.3 ThermoFisher Antibody Services Products Offered
  • 5.1.4 ThermoFisher Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.1.5 ThermoFisher Antibody Services Revenue by Product in 2024
  • 5.1.6 ThermoFisher Antibody Services Revenue by Application in 2024
  • 5.1.7 ThermoFisher Antibody Services Revenue by Geographic Area in 2024
  • 5.1.8 ThermoFisher Recent Developments
• 5.2 GenScript
  • 5.2.1 GenScript Corporation Information
  • 5.2.2 GenScript Description, Business Overview
  • 5.2.3 GenScript Antibody Services Products Offered
  • 5.2.4 GenScript Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.2.5 GenScript Antibody Services Revenue by Product in 2024
  • 5.2.6 GenScript Antibody Services Revenue by Application in 2024
  • 5.2.7 GenScript Antibody Services Revenue by Geographic Area in 2024
  • 5.2.8 GenScript Recent Developments
• 5.3 Abcam
  • 5.3.1 Abcam Corporation Information
  • 5.3.2 Abcam Description, Business Overview
  • 5.3.3 Abcam Antibody Services Products Offered
  • 5.3.4 Abcam Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.3.5 Abcam Antibody Services Revenue by Product in 2024
  • 5.3.6 Abcam Antibody Services Revenue by Application in 2024
  • 5.3.7 Abcam Antibody Services Revenue by Geographic Area in 2024
  • 5.3.8 Abcam Recent Developments
• 5.4 MBS
  • 5.4.1 MBS Corporation Information
  • 5.4.2 MBS Description, Business Overview
  • 5.4.3 MBS Antibody Services Products Offered
  • 5.4.4 MBS Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.4.5 MBS Antibody Services Revenue by Product in 2024
  • 5.4.6 MBS Antibody Services Revenue by Application in 2024
  • 5.4.7 MBS Antibody Services Revenue by Geographic Area in 2024
  • 5.4.8 MBS Recent Developments
• 5.5 ROCKLAND
  • 5.5.1 ROCKLAND Corporation Information
  • 5.5.2 ROCKLAND Description, Business Overview
  • 5.5.3 ROCKLAND Antibody Services Products Offered
  • 5.5.4 ROCKLAND Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.5.5 ROCKLAND Antibody Services Revenue by Product in 2024
  • 5.5.6 ROCKLAND Antibody Services Revenue by Application in 2024
  • 5.5.7 ROCKLAND Antibody Services Revenue by Geographic Area in 2024
  • 5.5.8 ROCKLAND Recent Developments
• 5.6 ProSci
  • 5.6.1 ProSci Corporation Information
  • 5.6.2 ProSci Description, Business Overview
  • 5.6.3 ProSci Antibody Services Products Offered
  • 5.6.4 ProSci Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.6.5 ProSci Antibody Services Revenue by Product in 2024
  • 5.6.6 ProSci Antibody Services Revenue by Application in 2024
  • 5.6.7 ProSci Antibody Services Revenue by Geographic Area in 2024
  • 5.6.8 ProSci Recent Developments
• 5.7 Anaspec
  • 5.7.1 Anaspec Corporation Information
  • 5.7.2 Anaspec Description, Business Overview
  • 5.7.3 Anaspec Antibody Services Products Offered
  • 5.7.4 Anaspec Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.7.5 Anaspec Antibody Services Revenue by Product in 2024
  • 5.7.6 Anaspec Antibody Services Revenue by Application in 2024
  • 5.7.7 Anaspec Antibody Services Revenue by Geographic Area in 2024
  • 5.7.8 Anaspec Recent Developments
• 5.8 Bio-Rad
  • 5.8.1 Bio-Rad Corporation Information
  • 5.8.2 Bio-Rad Description, Business Overview
  • 5.8.3 Bio-Rad Antibody Services Products Offered
  • 5.8.4 Bio-Rad Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.8.5 Bio-Rad Antibody Services Revenue by Product in 2024
  • 5.8.6 Bio-Rad Antibody Services Revenue by Application in 2024
  • 5.8.7 Bio-Rad Antibody Services Revenue by Geographic Area in 2024
  • 5.8.8 Bio-Rad Recent Developments
• 5.9 Covance
  • 5.9.1 Covance Corporation Information
  • 5.9.2 Covance Description, Business Overview
  • 5.9.3 Covance Antibody Services Products Offered
  • 5.9.4 Covance Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.9.5 Covance Antibody Services Revenue by Product in 2024
  • 5.9.6 Covance Antibody Services Revenue by Application in 2024
  • 5.9.7 Covance Antibody Services Revenue by Geographic Area in 2024
  • 5.9.8 Covance Recent Developments
• 5.10 Capra Science
  • 5.10.1 Capra Science Corporation Information
  • 5.10.2 Capra Science Description, Business Overview
  • 5.10.3 Capra Science Antibody Services Products Offered
  • 5.10.4 Capra Science Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.10.5 Capra Science Antibody Services Revenue by Product in 2024
  • 5.10.6 Capra Science Antibody Services Revenue by Application in 2024
  • 5.10.7 Capra Science Antibody Services Revenue by Geographic Area in 2024
  • 5.10.8 Capra Science Recent Developments
• 5.11 Innovagen
  • 5.11.1 Innovagen Corporation Information
  • 5.11.2 Innovagen Description, Business Overview
  • 5.11.3 Innovagen Antibody Services Products Offered
  • 5.11.4 Innovagen Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.11.5 Innovagen Antibody Services Revenue by Product in 2024
  • 5.11.6 Innovagen Antibody Services Revenue by Application in 2024
  • 5.11.7 Innovagen Antibody Services Revenue by Geographic Area in 2024
  • 5.11.8 Innovagen Recent Developments
• 5.12 APS
  • 5.12.1 APS Corporation Information
  • 5.12.2 APS Description, Business Overview
  • 5.12.3 APS Antibody Services Products Offered
  • 5.12.4 APS Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.12.5 APS Antibody Services Revenue by Product in 2024
  • 5.12.6 APS Antibody Services Revenue by Application in 2024
  • 5.12.7 APS Antibody Services Revenue by Geographic Area in 2024
  • 5.12.8 APS Recent Developments
• 5.13 Randox
  • 5.13.1 Randox Corporation Information
  • 5.13.2 Randox Description, Business Overview
  • 5.13.3 Randox Antibody Services Products Offered
  • 5.13.4 Randox Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.13.5 Randox Antibody Services Revenue by Product in 2024
  • 5.13.6 Randox Antibody Services Revenue by Application in 2024
  • 5.13.7 Randox Antibody Services Revenue by Geographic Area in 2024
  • 5.13.8 Randox Recent Developments
• 5.14 GL Biochem
  • 5.14.1 GL Biochem Corporation Information
  • 5.14.2 GL Biochem Description, Business Overview
  • 5.14.3 GL Biochem Antibody Services Products Offered
  • 5.14.4 GL Biochem Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.14.5 GL Biochem Antibody Services Revenue by Product in 2024
  • 5.14.6 GL Biochem Antibody Services Revenue by Application in 2024
  • 5.14.7 GL Biochem Antibody Services Revenue by Geographic Area in 2024
  • 5.14.8 GL Biochem Recent Developments
• 5.15 Abgent
  • 5.15.1 Abgent Corporation Information
  • 5.15.2 Abgent Description, Business Overview
  • 5.15.3 Abgent Antibody Services Products Offered
  • 5.15.4 Abgent Antibody Services Revenue and Gross Margin (2020-2025)
  • 5.15.5 Abgent Antibody Services Revenue by Product in 2024
  • 5.15.6 Abgent Antibody Services Revenue by Application in 2024
  • 5.15.7 Abgent Antibody Services Revenue by Geographic Area in 2024
  • 5.15.8 Abgent Recent Developments

6 North America

• 6.1 North America Antibody Services Market Size YoY Growth 2020-2031
• 6.2 North America Antibody Services Market Facts & Figures by Country (2020-2031)
• 6.3 North America Antibody Services Revenue by Type (2020-2025)
• 6.4 North America Antibody Services Revenue by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Antibody Services Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Antibody Services Market Facts & Figures by Region (2020-2031)
• 7.3 Asia-Pacific Antibody Services Revenue by Type (2020-2025)
• 7.4 Asia-Pacific Antibody Services Revenue by Application (2020-2025)

8 Europe

• 8.1 Europe Antibody Services Market Size YoY Growth 2020-2031
• 8.2 Europe Antibody Services Market Facts & Figures by Country (2020-2031)
• 8.3 Europe Antibody Services Revenue by Type (2020-2025)
• 8.4 Europe Antibody Services Revenue by Application (2020-2025)

9 Latin America

• 9.1 Latin America Antibody Services Market Size YoY Growth 2020-2031
• 9.2 Latin America Antibody Services Market Facts & Figures by Country (2020-2031)
• 9.3 Latin America Antibody Services Revenue by Type (2020-2025)
• 9.4 Latin America Antibody Services Revenue by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Antibody Services Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Antibody Services Market Facts & Figures by Country (2020-2031)
• 10.3 Middle East and Africa Antibody Services Revenue by Type (2020-2025)
• 10.4 Middle East and Africa Antibody Services Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Antibody Services Supply Chain Analysis
• 11.2 Antibody Services Key Raw Materials and Upstream Suppliers
• 11.3 Antibody Services Clients Analysis
• 11.4 Antibody Services Sales Channel and Sales Model Analysis
  • 11.4.1 Antibody Services Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Antibody Services Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Antibody Services Distributors

12 Antibody Services Market Dynamics

• 12.1 Antibody Services Industry Trends
• 12.2 Antibody Services Market Drivers
• 12.3 Antibody Services Market Challenges
• 12.4 Antibody Services Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Antibody Services Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Antibody Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Antibody Services Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Antibody Services Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Antibody Services Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Antibody Services Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Antibody Services Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Antibody Services Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Antibody Services Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Antibody Services Revenue by Company (2020-2025) & (US$ Million)

Table 11. Antibody Services Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Antibody Services Players by Revenue (US$ Million) in 2024

Table 13. Global Antibody Services Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Antibody Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Services as of 2024)

Table 15. Global Antibody Services Companies Headquarters

Table 16. Date of International Companies Enter into Antibody Services Market

Table 17. Global Antibody Services Companies Product & Service

Table 18. Global Antibody Services Mergers & Acquisitions, Expansion Plans

Table 19. ThermoFisher Corporation Information

Table 20. ThermoFisher Description and Business Overview

Table 21. ThermoFisher Antibody Services Product

Table 22. ThermoFisher Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. ThermoFisher Revenue Proportion of Antibody Services by Product in 2024

Table 24. ThermoFisher Revenue Proportion of Antibody Services by Application in 2024

Table 25. ThermoFisher Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 26. ThermoFisher Recent Developments

Table 27. GenScript Corporation Information

Table 28. GenScript Description and Business Overview

Table 29. GenScript Antibody Services Product

Table 30. GenScript Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. GenScript Revenue Proportion of Antibody Services by Product in 2024

Table 32. GenScript Revenue Proportion of Antibody Services by Application in 2024

Table 33. GenScript Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 34. GenScript Recent Developments

Table 35. Abcam Corporation Information

Table 36. Abcam Description and Business Overview

Table 37. Abcam Antibody Services Product

Table 38. Abcam Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Abcam Revenue Proportion of Antibody Services by Product in 2024

Table 40. Abcam Revenue Proportion of Antibody Services by Application in 2024

Table 41. Abcam Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 42. Abcam Recent Developments

Table 43. MBS Corporation Information

Table 44. MBS Description and Business Overview

Table 45. MBS Antibody Services Product

Table 46. MBS Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. MBS Revenue Proportion of Antibody Services by Product in 2024

Table 48. MBS Revenue Proportion of Antibody Services by Application in 2024

Table 49. MBS Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 50. MBS Recent Developments

Table 51. ROCKLAND Corporation Information

Table 52. ROCKLAND Description and Business Overview

Table 53. ROCKLAND Antibody Services Product

Table 54. ROCKLAND Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. ROCKLAND Revenue Proportion of Antibody Services by Product in 2024

Table 56. ROCKLAND Revenue Proportion of Antibody Services by Application in 2024

Table 57. ROCKLAND Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 58. ROCKLAND Recent Developments

Table 59. ProSci Corporation Information

Table 60. ProSci Description and Business Overview

Table 61. ProSci Antibody Services Product

Table 62. ProSci Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. ProSci Revenue Proportion of Antibody Services by Product in 2024

Table 64. ProSci Revenue Proportion of Antibody Services by Application in 2024

Table 65. ProSci Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 66. ProSci Recent Developments

Table 67. Anaspec Corporation Information

Table 68. Anaspec Description and Business Overview

Table 69. Anaspec Antibody Services Product

Table 70. Anaspec Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Anaspec Revenue Proportion of Antibody Services by Product in 2024

Table 72. Anaspec Revenue Proportion of Antibody Services by Application in 2024

Table 73. Anaspec Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 74. Anaspec Recent Developments

Table 75. Bio-Rad Corporation Information

Table 76. Bio-Rad Description and Business Overview

Table 77. Bio-Rad Antibody Services Product

Table 78. Bio-Rad Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. Bio-Rad Revenue Proportion of Antibody Services by Product in 2024

Table 80. Bio-Rad Revenue Proportion of Antibody Services by Application in 2024

Table 81. Bio-Rad Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 82. Bio-Rad Recent Developments

Table 83. Covance Corporation Information

Table 84. Covance Description and Business Overview

Table 85. Covance Antibody Services Product

Table 86. Covance Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. Covance Revenue Proportion of Antibody Services by Product in 2024

Table 88. Covance Revenue Proportion of Antibody Services by Application in 2024

Table 89. Covance Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 90. Covance Recent Developments

Table 91. Capra Science Corporation Information

Table 92. Capra Science Description and Business Overview

Table 93. Capra Science Antibody Services Product

Table 94. Capra Science Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Capra Science Revenue Proportion of Antibody Services by Product in 2024

Table 96. Capra Science Revenue Proportion of Antibody Services by Application in 2024

Table 97. Capra Science Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 98. Capra Science Recent Developments

Table 99. Innovagen Corporation Information

Table 100. Innovagen Description and Business Overview

Table 101. Innovagen Antibody Services Product

Table 102. Innovagen Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Innovagen Revenue Proportion of Antibody Services by Product in 2024

Table 104. Innovagen Revenue Proportion of Antibody Services by Application in 2024

Table 105. Innovagen Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 106. Innovagen Recent Developments

Table 107. APS Corporation Information

Table 108. APS Description and Business Overview

Table 109. APS Antibody Services Product

Table 110. APS Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 111. APS Revenue Proportion of Antibody Services by Product in 2024

Table 112. APS Revenue Proportion of Antibody Services by Application in 2024

Table 113. APS Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 114. APS Recent Developments

Table 115. Randox Corporation Information

Table 116. Randox Description and Business Overview

Table 117. Randox Antibody Services Product

Table 118. Randox Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 119. Randox Revenue Proportion of Antibody Services by Product in 2024

Table 120. Randox Revenue Proportion of Antibody Services by Application in 2024

Table 121. Randox Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 122. Randox Recent Developments

Table 123. GL Biochem Corporation Information

Table 124. GL Biochem Description and Business Overview

Table 125. GL Biochem Antibody Services Product

Table 126. GL Biochem Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 127. GL Biochem Revenue Proportion of Antibody Services by Product in 2024

Table 128. GL Biochem Revenue Proportion of Antibody Services by Application in 2024

Table 129. GL Biochem Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 130. GL Biochem Recent Developments

Table 131. Abgent Corporation Information

Table 132. Abgent Description and Business Overview

Table 133. Abgent Antibody Services Product

Table 134. Abgent Antibody Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 135. Abgent Revenue Proportion of Antibody Services by Product in 2024

Table 136. Abgent Revenue Proportion of Antibody Services by Application in 2024

Table 137. Abgent Revenue Proportion of Antibody Services by Geographic Area in 2024

Table 138. Abgent Recent Developments

Table 139. North America Antibody Services Revenue by Country (2020-2025) & (US$ Million)

Table 140. North America Antibody Services Revenue by Country (2026-2031) & (US$ Million)

Table 141. North America Antibody Services Revenue by Type (2020-2025) & (US$ Million)

Table 142. North America Antibody Services Revenue by Application (2020-2025) & (US$ Million)

Table 143. Asia-Pacific Antibody Services Revenue by Region (2020-2025) & (US$ Million)

Table 144. Asia-Pacific Antibody Services Revenue by Region (2026-2031) & (US$ Million)

Table 145. Asia-Pacific Antibody Services Revenue by Type (2020-2025) & (US$ Million)

Table 146. Asia-Pacific Antibody Services Revenue by Application (2020-2025) & (US$ Million)

Table 147. Europe Antibody Services Revenue by Country (2020-2025) & (US$ Million)

Table 148. Europe Antibody Services Revenue by Country (2026-2031) & (US$ Million)

Table 149. Europe Antibody Services Revenue by Type (2020-2025) & (US$ Million)

Table 150. Europe Antibody Services Revenue by Application (2020-2025) & (US$ Million)

Table 151. Latin America Antibody Services Revenue by Country (2020-2025) & (US$ Million)

Table 152. Latin America Antibody Services Revenue by Country (2026-2031) & (US$ Million)

Table 153. Latin America Antibody Services Revenue by Type (2020-2025) & (US$ Million)

Table 154. Latin America Antibody Services Revenue by Application (2020-2025) & (US$ Million)

Table 155. Middle East and Africa Antibody Services Revenue by Country (2020-2025) & (US$ Million)

Table 156. Middle East and Africa Antibody Services Revenue by Country (2026-2031) & (US$ Million)

Table 157. Middle East and Africa Antibody Services Revenue by Type (2020-2025) & (US$ Million)

Table 158. Middle East and Africa Antibody Services Revenue by Application (2020-2025) & (US$ Million)

Table 159. Antibody Services Key Raw Materials, Industry Status and Trend

Table 160. Antibody Services Key Raw Materials and Upstream Suppliers

Table 161. Antibody Services Clients Status and Trend

Table 162. Antibody Services Typical Clients

Table 163. Antibody Services Distributors

Table 164. Antibody Services Market Trends

Table 165. Antibody Services Market Drivers

Table 166. Antibody Services Market Challenges

Table 167. Antibody Services Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Antibody Services Product Picture

Figure 2. Global Antibody Services Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Antibody Services Revenue Market Share by Type in 2024 & 2031

Figure 4. Monoclonal Product Picture

Figure 5. Polyclonal Product Picture

Figure 6. Others Product Picture

Figure 7. Global Antibody Services Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Antibody Services Revenue Market Share by Application in 2024 & 2031

Figure 9. BioScience Companies

Figure 10. BioScience Research Institutions

Figure 11. Hospitals

Figure 12. Other

Figure 13. Antibody Services Report Years Considered

Figure 14. Global Antibody Services Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Antibody Services Market Size (2020-2031) & (US$ Million)

Figure 16. Global Antibody Services Market Size Market Share by Region: 2024 Versus 2031

Figure 17. Global Antibody Services Revenue Market Share by Region (2020-2031)

Figure 18. Global Antibody Services Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Global Antibody Services Revenue Market Share Forecast by Application (2020-2031)

Figure 20. Monoclonal of Antibody Services Revenue Market Share by Application, 2024 VS 2031

Figure 21. Polyclonal of Antibody Services Revenue Market Share by Application, 2024 VS 2031

Figure 22. Others of Antibody Services Revenue Market Share by Application, 2024 VS 2031

Figure 23. Antibody Services Revenue Share by Company (2024)

Figure 24. Antibody Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Monoclonal Revenue Proportion by Company in 2024

Figure 26. Polyclonal Revenue Proportion by Company in 2024

Figure 27. Others Revenue Proportion by Company in 2024

Figure 28. North America Antibody Services Revenue 2020-2031 (US$ Million)

Figure 29. North America Antibody Services Revenue Market Share by Type (2020-2025)

Figure 30. North America Antibody Services Revenue Market Share by Application (2020-2025)

Figure 31. Asia-Pacific Antibody Services Revenue 2020-2031 (US$ Million)

Figure 32. Asia-Pacific Antibody Services Revenue Market Share by Region (2020-2031)

Figure 33. Asia-Pacific Antibody Services Revenue Market Share by Type (2020-2025)

Figure 34. Asia-Pacific Antibody Services Revenue Market Share by Application (2020-2025)

Figure 35. Europe Antibody Services Revenue Growth Rate 2020-2031 (US$ Million)

Figure 36. Europe Antibody Services Revenue Market Share by Country (2020-2031)

Figure 37. Europe Antibody Services Revenue Market Share by Type (2020-2025)

Figure 38. Europe Antibody Services Revenue Market Share by Application (2020-2025)

Figure 39. Latin America Antibody Services Revenue Growth Rate 2020-2031 (US$ Million)

Figure 40. Latin America Antibody Services Revenue Market Share by Country (2020-2031)

Figure 41. Latin America Antibody Services Revenue Market Share by Type (2020-2025)

Figure 42. Latin America Antibody Services Revenue Market Share by Application (2020-2025)

Figure 43. Middle East and Africa Antibody Services Revenue Growth Rate 2020-2031 (US$ Million)

Figure 44. Middle East and Africa Antibody Services Revenue Market Share by Country (2020-2031)

Figure 45. Middle East and Africa Antibody Services Revenue Market Share by Type (2020-2025)

Figure 46. Middle East and Africa Antibody Services Revenue Market Share by Application (2020-2025)

Figure 47. Antibody Services Supply Chain (Upstream and Downstream Market)

Figure 48. Global Production Market Share of Antibody Services Raw Materials by Region in 2024

Figure 49. Antibody Services Distribution Channels

Figure 50. Global Antibody Services Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 51. Global Antibody Services Percentage 2020-2031: Online Sales VS Offline Sales

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed